Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96

NCT02122822 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma

Interventions

BIOLOGICAL: gp96

Sponsor

Cure&Sure Biotech Co., LTD

Collaborators

[object Object]